I have quality in Boeing and Corning, and now INCY which I sold recently. I don't know what is going on behind the scenes for sure. I suspect there are negotiations going on and that we could be in a silent period. I can't justify Roche walking unless they are protecting their own adjuvants and don't want a competitor knowing what they are doing. Just a guess on my part due to the golden parachute to the CMO on November 7th. Too much happened in a short time without good explanations. That happens when changes in ownership or management is a possibility. Things like that make me think, so it is all just my opinion. I think the same thing is going on here in Wilmington with INCY, again just my opinion. I do try to look down the road and be ahead of the trade which is really difficult, and seem more so every day. What I post is usually to illicit other replies from some of the thinkers and more knowledgeable here and hope it is taken that way and not and indictment of the company. I also think management should be accountable to the shareholders, that ain't gonna happen.
Nothing you said I can disagree with. Money in the bank is good, just not enough. Partnerships are necessity but longs like Permit say we don't need them, more money for us. Couldn't be more wrong, no thought process there. All these trials cost big and we need the financial help and the validation it brings. When it comes to marketing, we need them even more. These retail $2 investors can't see what all this entails and it shows in their posts. Enjoy some of the commentary here, but not much of it. "More starting soon" and a portfolio that could choke a horse. The more money we have available the faster to trial and market. That's the bottom line.
Well, that's my feeling this morning anyway. So much going on for one man to handle. Burden is huge there with trials on going and new ones to get started. Gotta stay focused.
Is huge in this business and this year's results are going to test this company's credibility for sure. Lots of raised expectations to fulfill and not much time left to do it. Advancing the science was almost right on target.
Financially, it was another story and one that will haunt us for a long time it appears. Raising cash at this point is going to be much more costly than it could of been and that is weighing heavily on the pps. Without partnerships to ease the process, we will drift lower and the RS will hang over us much longer than it should of. Timing for that issue was critical and so far it seems to have been done too early, time will eventually tell the whole story. Wishing Dr. Kim and the BOD better success in 2015, but would rather see some change at the top. Would like to see Dr. Kim in the lab, too many balls in the air for a fast growing small company on the verge of new and exciting vaccines for cancer and diseases. Surely the responsibilities are enormous for one man.
If they found it so attractive in July, why aren't we seeing more buying here? From $17 to $8 it is having an effect. Insiders standing pat because they are so far under water. Next round of financing at these levels is awful for shareholders, talk about costly.
By the time we find out, news will not move us much. Bad taste left by raised expectations by Dr. Kim. This has no strength and looking to go to dollar land pre split. Al the pumpers are screaming 400%, but you can't grow on yesterday's news.
The pps and the market says he was wrong. I can see this company in danger of big pharma trying to steal it.
With a market cap dropping like this and our science and pipeline being what it is, I would jump at an opportunity to throw an offer out there. Big Pharma isn't stupid, they are running out of patent protection on a lot of drugs and to pick this baby up cheap would be a great move. From seventeen to eight fifty and still falling would certainly have my attention. Only sixty million shares and change, I would be accumulating and gaining strength to force a sale. Wharton education or not, I am not convinced he has the experience he needs. Sorry retail.
I would hope they are in a quiet period. I'ld hate to think that they have nothing at this point after the good Dr. ran the pps up on dwarfing and partnership agreements this year. Time is getting short and one would think a little PR in support of the shareholders was in order. Conferences don't seem to be a viable way to gain support as we have had ten since September and the pps continues to suffer. I took some off at 10 but held too much thinking it would bottom well above this. The info seems to be the same every time, and he doesn't sound inspiring any more. Tough job for him with the pps and market cap dropping like this.
Wonder if these guys and gals realize just how many times we have bought the dip thinking Toman was telling us the truth. Hope you bought the dip should be engraved on our tombstones with a thank you microvision.